Educational Qualifications:

1. Massachusetts General Hospital, Harvard Medical School, Research fellow, from October 2023 to present.
2. Department of Hematology, Division of Life Sciences and Medicine, University of Science and Technology of China, Associate research fellow, from September 2022 to present.
3. School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P.R. China Postdoc, from September 2019 to 2022.
4. School of Life Sciences, University of Science and Technology of China, Hefei, China Ph.D. in Immunology, from September 2013 to June 2019.
5. Bethune Medical Department, Jilin University, Changchun, P.R. China Bachelor of Medicine, from September 2008 to June 2013.

Professional Experience:

1. Two-year experience served as chairman of postgraduate in School of Life Sciences, University of Science and Technology of China.
2. Six-year experience served as monitor in School of Life Sciences, University of Science and Technology of China.
3. Highly self-motivated Postdoc in Immunology with strong collaboration skills.
4. Ten-year laboratory experience in cell biology and immunological research in leukemia, liver cancer and Chronic hepatitis B .
5. Experimental techniques: Flow Cytometry, immunofluorescence, histology and immunohistochemistry analysis, enzyme-linked immunosorbent assay, western blot, PCR, three-dimensional cell culture, proficient in real-time cell analyzer.

Achievements:

1. A key member of the "Huang Danian" teacher team. (Ministry of Education, China).
2. Member of American Society of Hematology (ASH).
3. Member of Chinese Society of Immunology.

• Tumor Microenvironment
• Cancer Therapy

• Dongyao Wang, Zimin Sun*, Xiaoyu Zhu*, Xiaohu Zheng, Yonggang Zhou, Yichen Lu, Peidong Yan, Huiru Wang, Huilan Liu, Jing Jin, Huaiping Zhu, Rui Sun, Yi Wang, Binqing Fu, Zhigang Tian and Haiming Wei*. GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post-allo-HSCT. Blood. 2022 Dec 29;140(26):2788-2804.
• Dongyao Wang#, Binqing Fu#, Xiaokun Shen, Chuang Guo, Yanyan Liu, Junfei Zhang, Rui Sun, Ying Ye, Jiabin Li*, Zhigang Tian*, Haiming Wei*. Restoration of HBV-specific CD8+ T cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy. Signal Transduction and Targeted Therapy. 2021 Nov 5;6(1):376.
• Dongyao Wang; Xiaohu Zheng; Binqing Fu; Zhigang Nian; Yeben Qian; Rui Sun; Zhigang Tian*; Haiming Wei*; Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling, EBioMedicine. 2019, 46(2019):119-132.
• Jing Jin#, Lin Ba#, Dongyao Wang#, Peidong Yan, Xiaohu Zheng, Haiming Wei, Hening Lin*, Chen Ding*, Yi Wang*. SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. EMBO Reports. 2023 May 4;24(5):e56052.
• Binqing Fu#, Dongyao Wang#, Xiaokun Shen, Chuang Guo, Yanyan Liu, Ying Ye, Rui Sun, Jiabin Li*, Zhigang Tian* and Haiming Wei*. Immunomodulation Induced During Interferon-a Therapy Impairs the Anti-HBV Immune Response Through CD24+CD38hi B Cells. Frontiers in Immunology. 2020, 11:591269.
• Xingchi Chen#, Dongyao Wang #, Xiaoyu Zhu*. Application of double-negative T cells in haematological malignancies: recent progress and future directions. Biomarker research. 2022 Mar 14;10(1):11.
• Baolin Tang#, Jong Bok Lee#, Siqi Cheng#, Tianzhong Pan#, Wen Yao, Dongyao Wang, Meijuan Tu, Zhiqiang Xiang, Xiandeng Chu, Liangquan Geng, Ping Qiang, Pingping Teng, Guangyu Sun, Huilan Liu, Jian Wang, Aaron D Schimmer, Liming Yang, Zimin Sun*, Li Zhang*, Xiaoyu Zhu*. Allogeneic double-negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic stem cell transplantation: A first-in-human phase I study. American journal of hematology. 2022 Jul;97(7): E264-E267.

No content available to display!!!

No content available to display!!!